$AVXS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AveXis, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AveXis, Inc.. Get notifications about new insider transactions in AveXis, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 15 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | D | 133.80 | 2,905 | 388,689 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | D | 69.25 | 2,454 | 169,940 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | D | 20.00 | 35,552 | 711,040 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Buy | D | 0.00 | 1,106 | 0 | 0 | -1,106 to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Verwiel Frank | Director | Option Exercise | D | 133.80 | 2,905 | 388,689 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Verwiel Frank | Director | Option Exercise | D | 69.25 | 2,454 | 169,940 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Verwiel Frank | Director | Option Exercise | D | 20.00 | 26,496 | 529,920 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Verwiel Frank | Director | Sell | D | 0.00 | 1,106 | 0 | 0 | 1.1 K to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Smith Lori J. | SVP-Chief Human Res ... | Option Exercise | D | 133.80 | 9,233 | 1,235,375 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Smith Lori J. | SVP-Chief Human Res ... | Option Exercise | D | 77.24 | 1,925 | 148,687 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Smith Lori J. | SVP-Chief Human Res ... | Option Exercise | D | 68.40 | 24,400 | 1,668,960 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Smith Lori J. | SVP-Chief Human Res ... | Sell | D | 0.00 | 2,308 | 0 | 0 | 2.3 K to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Option Exercise | D | 133.80 | 2,905 | 388,689 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Option Exercise | D | 69.25 | 7,755 | 537,034 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Sell | D | 0.00 | 1,106 | 0 | 0 | 1.1 K to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Session R.A. II | Sr. VP, Corp Strate ... | Option Exercise | D | 133.80 | 6,572 | 879,334 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Session R.A. II | Sr. VP, Corp Strate ... | Option Exercise | D | 77.24 | 1,282 | 99,022 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Session R.A. II | Sr. VP, Corp Strate ... | Option Exercise | D | 79.75 | 35,950 | 2,867,013 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Session R.A. II | Sr. VP, Corp Strate ... | Sell | D | 0.00 | 1,667 | 0 | 0 | 1.7 K to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | D | 133.80 | 44,000 | 5,887,200 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | D | 77.24 | 96,000 | 7,415,040 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | D | 42.61 | 110,000 | 4,687,100 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | D | 15.94 | 728,300 | 11,609,102 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | D | 0.00 | 11,000 | 0 | 0 | 11 K to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | D | 0.00 | 9,906 | 0 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | A | 0.00 | 9,906 | 0 | 9,906 | |
May 15 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | D | 133.80 | 15,000 | 2,007,000 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | D | 77.24 | 25,200 | 1,946,448 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | D | 42.61 | 37,750 | 1,608,528 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | D | 18.47 | 178,494 | 3,296,784 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | D | 0.00 | 3,800 | 0 | 0 | 3.8 K to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Modi Rick | Chief Business Offi ... | Option Exercise | D | 133.80 | 10,000 | 1,338,000 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Modi Rick | Chief Business Offi ... | Option Exercise | D | 77.24 | 7,940 | 613,286 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Modi Rick | Chief Business Offi ... | Option Exercise | D | 57.88 | 61,000 | 3,530,680 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Modi Rick | Chief Business Offi ... | Sell | D | 0.00 | 2,500 | 0 | 0 | 2.5 K to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | D | 2.57 | 103,478 | 265,938 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | D | 2.57 | 137,154 | 352,486 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | D | 133.80 | 2,905 | 388,689 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | D | 69.25 | 2,454 | 169,940 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | D | 20.00 | 26,496 | 529,920 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Sell | D | 0.00 | 25,293 | 0 | 0 | 25.3 K to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Sell | D | 0.00 | 1,201,160 | 0 | 0 | 1.2 M to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Sell | D | 0.00 | 228,752 | 0 | 0 | 228.8 K to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Option Exercise | D | 0.00 | 9,154 | 0 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Option Exercise | A | 0.00 | 9,154 | 0 | 9,154 | |
May 15 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Option Exercise | D | 133.80 | 15,000 | 2,007,000 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Option Exercise | D | 77.24 | 27,827 | 2,149,357 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Option Exercise | D | 42.61 | 37,750 | 1,608,528 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Option Exercise | D | 18.17 | 141,800 | 2,576,506 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | D | 0.00 | 3,800 | 0 | 0 | 3.8 K to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Koh Bong Y | Director | Option Exercise | D | 133.80 | 2,905 | 388,689 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Koh Bong Y | Director | Option Exercise | D | 69.25 | 2,454 | 169,940 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Koh Bong Y | Director | Option Exercise | D | 20.00 | 26,496 | 529,920 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Koh Bong Y | Director | Sell | D | 0.00 | 1,035,657 | 0 | 0 | 1 M to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Koh Bong Y | Director | Sell | D | 0.00 | 1,106 | 0 | 0 | 1.1 K to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Option Exercise | D | 0.00 | 8,778 | 0 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Option Exercise | A | 0.00 | 8,778 | 0 | 8,778 | |
May 15 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Option Exercise | D | 133.80 | 15,000 | 2,007,000 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Option Exercise | D | 77.24 | 27,827 | 2,149,357 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Option Exercise | D | 42.61 | 37,750 | 1,608,528 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Option Exercise | D | 18.17 | 141,800 | 2,576,506 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | D | 0.00 | 8,800 | 0 | 0 | 8.8 K to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Option Exercise | D | 133.80 | 2,905 | 388,689 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Option Exercise | D | 69.25 | 2,454 | 169,940 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Option Exercise | D | 20.00 | 26,496 | 529,920 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Sell | D | 0.00 | 1,106 | 0 | 0 | 1.1 K to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Option Exercise | D | 133.80 | 15,000 | 2,007,000 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Option Exercise | D | 77.24 | 32,501 | 2,510,377 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | D | 0.00 | 1,764,142 | 0 | 0 | 1.8 M to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Johannesen Michael | General Counsel | Option Exercise | D | 133.80 | 10,000 | 1,338,000 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Johannesen Michael | General Counsel | Option Exercise | D | 77.24 | 22,500 | 1,737,900 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Johannesen Michael | General Counsel | Option Exercise | D | 36.02 | 44,700 | 1,610,094 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Johannesen Michael | General Counsel | Sell | D | 0.00 | 2,500 | 0 | 0 | 2.5 K to 0 (-100.00 %) |
May 15 2018 | AVXS | AveXis, Inc. | Donenberg Phillip B. | Chief Financial Off ... | Option Exercise | D | 133.80 | 15,000 | 2,007,000 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Donenberg Phillip B. | Chief Financial Off ... | Option Exercise | D | 100.52 | 10,000 | 1,005,200 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Donenberg Phillip B. | Chief Financial Off ... | Option Exercise | D | 88.08 | 4,406 | 388,080 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Donenberg Phillip B. | Chief Financial Off ... | Option Exercise | D | 77.24 | 5,594 | 432,081 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Donenberg Phillip B. | Chief Financial Off ... | Option Exercise | D | 37.58 | 20,000 | 751,600 | 0 | |
May 15 2018 | AVXS | AveXis, Inc. | Donenberg Phillip B. | Chief Financial Off ... | Buy | D | 0.00 | 3,800 | 0 | 3,800 | 0 to 3.8 K |
Apr 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 123.16 | 846 | 104,193 | 1,755,602 | 1.8 M to 1.8 M (-0.05 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 122.29 | 1,182 | 144,547 | 1,756,558 | 1.8 M to 1.8 M (-0.07 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 121.64 | 929 | 113,004 | 1,757,630 | 1.8 M to 1.8 M (-0.05 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 120.18 | 3,179 | 382,052 | 1,758,559 | 1.8 M to 1.8 M (-0.18 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 119.29 | 4,021 | 479,665 | 1,761,738 | 1.8 M to 1.8 M (-0.23 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 118.17 | 2,007 | 237,167 | 1,765,759 | 1.8 M to 1.8 M (-0.11 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Sell | S | 117.00 | 2,836 | 331,812 | 1,767,766 | 1.8 M to 1.8 M (-0.16 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Option Exercise | M | 18.17 | 2,000 | 36,340 | 141,800 | |
Apr 04 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 123.37 | 79 | 9,746 | 8,800 | 8.9 K to 8.8 K (-0.89 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 122.19 | 253 | 30,914 | 8,879 | 9.1 K to 8.9 K (-2.77 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 120.42 | 84 | 10,115 | 9,132 | 9.2 K to 9.1 K (-0.91 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 119.77 | 808 | 96,774 | 9,216 | 10 K to 9.2 K (-8.06 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 118.58 | 403 | 47,788 | 10,024 | 10.4 K to 10 K (-3.86 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Sell | S | 117.01 | 373 | 43,645 | 10,427 | 10.8 K to 10.4 K (-3.45 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Buy | M | 18.17 | 2,000 | 36,340 | 10,800 | 8.8 K to 10.8 K (+22.73 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Option Exercise | M | 18.17 | 5,000 | 90,850 | 141,800 | |
Apr 04 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 123.32 | 155 | 19,115 | 3,800 | 4 K to 3.8 K (-3.92 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 122.14 | 757 | 92,460 | 3,955 | 4.7 K to 4 K (-16.07 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 120.11 | 1,052 | 126,356 | 4,712 | 5.8 K to 4.7 K (-18.25 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 119.43 | 1,297 | 154,901 | 5,764 | 7.1 K to 5.8 K (-18.37 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 118.41 | 569 | 67,375 | 7,061 | 7.6 K to 7.1 K (-7.46 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Sell | S | 117.10 | 1,170 | 137,007 | 7,630 | 8.8 K to 7.6 K (-13.30 %) |
Apr 04 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Buy | M | 18.17 | 5,000 | 90,850 | 8,800 | 3.8 K to 8.8 K (+131.58 %) |
Mar 30 2018 | AVXS | AveXis, Inc. | Koh Bong Y | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
Mar 30 2018 | AVXS | AveXis, Inc. | Koh Bong Y | Director | Grant | A | 0.00 | 1,106 | 0 | 1,106 | 0 to 1.1 K |
Mar 30 2018 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
Mar 30 2018 | AVXS | AveXis, Inc. | Siffert Joao MD | Director | Grant | A | 0.00 | 1,106 | 0 | 1,106 | 0 to 1.1 K |
Mar 30 2018 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
Mar 30 2018 | AVXS | AveXis, Inc. | Kearney Terrence C | Director | Grant | A | 0.00 | 1,106 | 0 | 1,106 | 0 to 1.1 K |
Mar 30 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
Mar 30 2018 | AVXS | AveXis, Inc. | Manning Paul B | Director | Grant | A | 0.00 | 1,106 | 0 | 228,752 | 227.6 K to 228.8 K (+0.49 %) |
Mar 30 2018 | AVXS | AveXis, Inc. | Verwiel Frank | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
Mar 30 2018 | AVXS | AveXis, Inc. | Verwiel Frank | Director | Grant | A | 0.00 | 1,106 | 0 | 1,106 | 0 to 1.1 K |
Mar 30 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Option Exercise | A | 133.80 | 2,905 | 388,689 | 2,905 | |
Mar 30 2018 | AVXS | AveXis, Inc. | WELCH DANIEL G | Director | Grant | A | 0.00 | 1,106 | 0 | 1,106 | 0 to 1.1 K |
Mar 27 2018 | AVXS | AveXis, Inc. | Smith Lori J. | SVP-Chief Human Res ... | Option Exercise | A | 133.80 | 9,233 | 1,235,375 | 9,233 | |
Mar 27 2018 | AVXS | AveXis, Inc. | Smith Lori J. | SVP-Chief Human Res ... | Grant | A | 0.00 | 2,308 | 0 | 2,308 | 0 to 2.3 K |
Mar 27 2018 | AVXS | AveXis, Inc. | Session R.A. II | Sr. VP, Corp Strate ... | Option Exercise | A | 133.80 | 6,572 | 879,334 | 6,572 | |
Mar 27 2018 | AVXS | AveXis, Inc. | Session R.A. II | Sr. VP, Corp Strate ... | Grant | A | 0.00 | 1,667 | 0 | 1,667 | 0 to 1.7 K |
Mar 27 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | A | 133.80 | 15,000 | 2,007,000 | 15,000 | |
Mar 27 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Grant | A | 0.00 | 3,800 | 0 | 3,800 | 0 to 3.8 K |
Mar 27 2018 | AVXS | AveXis, Inc. | Modi Rick | Chief Business Offi ... | Option Exercise | A | 133.80 | 10,000 | 1,338,000 | 10,000 | |
Mar 27 2018 | AVXS | AveXis, Inc. | Modi Rick | Chief Business Offi ... | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Mar 27 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Option Exercise | A | 133.80 | 15,000 | 2,007,000 | 15,000 | |
Mar 27 2018 | AVXS | AveXis, Inc. | LITALIEN JAMES J | SrVP/Chief Reg&Qual ... | Grant | A | 0.00 | 3,800 | 0 | 3,800 | 0 to 3.8 K |
Mar 27 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Option Exercise | A | 133.80 | 15,000 | 2,007,000 | 15,000 | |
Mar 27 2018 | AVXS | AveXis, Inc. | Knudten Andrew F. | SrVP/Manufacture&Su ... | Grant | A | 0.00 | 3,800 | 0 | 8,800 | 5 K to 8.8 K (+76.00 %) |
Mar 27 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Option Exercise | A | 133.80 | 15,000 | 2,007,000 | 15,000 | |
Mar 27 2018 | AVXS | AveXis, Inc. | Kaspar Brian K. | Chief Scientific Of ... | Grant | A | 0.00 | 3,800 | 0 | 1,770,602 | 1.8 M to 1.8 M (+0.22 %) |
Mar 27 2018 | AVXS | AveXis, Inc. | Johannesen Michael | General Counsel | Option Exercise | A | 133.80 | 10,000 | 1,338,000 | 10,000 | |
Mar 27 2018 | AVXS | AveXis, Inc. | Johannesen Michael | General Counsel | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Mar 27 2018 | AVXS | AveXis, Inc. | Donenberg Phillip B. | Chief Financial Off ... | Option Exercise | A | 133.80 | 15,000 | 2,007,000 | 15,000 | |
Mar 27 2018 | AVXS | AveXis, Inc. | Donenberg Phillip B. | Chief Financial Off ... | Grant | A | 0.00 | 3,800 | 0 | 3,800 | 0 to 3.8 K |
Mar 27 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | A | 133.80 | 44,000 | 5,887,200 | 44,000 | |
Mar 27 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Grant | A | 0.00 | 11,000 | 0 | 11,000 | 0 to 11 K |
Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Option Exercise | M | 15.94 | 10,000 | 159,400 | 728,300 | |
Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 131.86 | 1,100 | 145,046 | 0 | 1.1 K to 0 (-100.00 %) |
Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 130.78 | 600 | 78,468 | 1,100 | 1.7 K to 1.1 K (-35.29 %) |
Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 129.66 | 4,800 | 622,368 | 1,700 | 6.5 K to 1.7 K (-73.85 %) |
Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 128.65 | 2,400 | 308,760 | 6,500 | 8.9 K to 6.5 K (-26.97 %) |
Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 127.65 | 700 | 89,355 | 8,900 | 9.6 K to 8.9 K (-7.29 %) |
Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Sell | S | 126.65 | 400 | 50,660 | 9,600 | 10 K to 9.6 K (-4.00 %) |
Mar 09 2018 | AVXS | AveXis, Inc. | Nolan Sean P. | President & CEO | Buy | M | 15.94 | 10,000 | 159,400 | 10,000 | 0 to 10 K |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Option Exercise | M | 18.47 | 1,780 | 32,877 | 178,494 | |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 128.91 | 50 | 6,446 | 0 | 50 to 0 (-100.00 %) |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 127.99 | 408 | 52,220 | 50 | 458 to 50 (-89.08 %) |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 126.95 | 504 | 63,983 | 458 | 962 to 458 (-52.39 %) |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 125.72 | 449 | 56,448 | 962 | 1.4 K to 962 (-31.82 %) |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 124.29 | 175 | 21,751 | 1,411 | 1.6 K to 1.4 K (-11.03 %) |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 123.16 | 120 | 14,779 | 1,586 | 1.7 K to 1.6 K (-7.03 %) |
Mar 05 2018 | AVXS | AveXis, Inc. | Nagendran Sukumar | Sr. VP & Chief Medi ... | Sell | S | 121.51 | 74 | 8,992 | 1,706 | 1.8 K to 1.7 K (-4.16 %) |